Phebra partners with University of Wollongong to develop drug for leukemia, pancreatic cancer

Phebra partners with University of Wollongong to develop drug for leukemia, pancreatic cancer Australian pharmaceutical firm Phebra has joined forces with the University of Wollongong (UOW) in a six-year collaboration agreement to conduct research and development (R&D) and trials for the treatment of acute myeloid leukemias and pancreatic cancer. Phebra’s CEO, Andre Vlok, expressed satisfaction…

Read More